Stock Research: AtriCure

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

AtriCure

NMQ:ATRC US04963C2098
84
  • Value
    53
  • Growth
    81
  • Safety
    Safety
    63
  • Combined
    87
  • Sentiment
    57
  • 360° View
    360° View
    84
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

AtriCure, Inc. provides technologies for treating atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. The company operates in the medical device industry. AtriCure's products are used in open-heart and minimally invasive surgical procedures. In the last fiscal year, the company had a market cap of $1,514 million, profits of $348 million, and revenue of $465 million, with 1300 employees.

more
Index
NASDAQ
D.J. US Medical Equipment
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
53 37 38 17
Growth
81 73 79 85
Safety
Safety
63 67 20 11
Sentiment
57 94 73 56
360° View
360° View
84 98 60 24
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
91 97 59 4
Opinions Change
63 77 50 30
Pro Holdings
n/a 73 55 100
Market Pulse
46 71 87 75
Sentiment
57 94 73 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
53 37 38 17
Growth
81 73 79 85
Safety Safety
63 67 20 11
Combined
87 72 32 22
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
57 40 45 25
Price vs. Earnings (P/E)
56 56 56 26
Price vs. Book (P/B)
55 46 55 43
Dividend Yield
1 1 1 1
Value
53 37 38 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
56 64 61 59
Profit Growth
91 48 79 98
Capital Growth
72 64 86 41
Stock Returns
59 71 35 77
Growth
81 73 79 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
65 75 58 53
Refinancing
55 34 21 13
Liquidity
36 51 40 34
Safety Safety
63 67 20 11

Similar Stocks

Discover high‑ranked alternatives to AtriCure and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: